CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity

被引:17
作者
Lynch, CL
Hale, JJ
Budhu, RJ
Gentry, AL
Finke, PE
Caldwell, CG
Mills, SG
MacCoss, M
Shen, DM
Chapman, KT
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Cascieri, MA
Carella, A
Carver, G
Karen, H
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Emini, E
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA
关键词
D O I
10.1021/ol034707c
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
graphic A novel approach to alpha,alpha-disubstituted-beta-amino acids (beta(2,2)-amino acids) was employed in the synthesis of a series of 3-(pyrrolidin-1-yl)-propionic acids possessing high affinity for the CCR5 receptor and potent anti-HIV activity. The rat pharmacokinetics for these new analogues featured higher bioavailabilities and lower rates of clearance as compared to cyclopentane 1.
引用
收藏
页码:2473 / 2475
页数:3
相关论文
共 10 条
[1]  
Abele S, 2000, EUR J ORG CHEM, V2000, P1
[2]   TETRAMETHYL 1,1,4,4-CYCLOHEXANETETRACARBOXYLATE - PREPARATION AND CONVERSION TO KEY PRECURSORS OF FLUORINATED, STEREOCHEMICALLY DEFINED CYCLOHEXANES [J].
DAVIS, CR ;
SWENSON, DC ;
BURTON, DJ .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (24) :6843-6850
[3]  
FINKE PE, 2002, INFL RES ASS 11 NAT
[4]   1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements [J].
Hale, JJ ;
Budhu, RJ ;
Mills, SG ;
MacCoss, M ;
Malkowitz, L ;
Siciliano, S ;
Gould, SL ;
DeMartino, JA ;
Springer, MS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) :1437-1440
[5]   Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells [J].
Hazuda, DJ ;
Felock, P ;
Witmer, M ;
Wolfe, A ;
Stillmock, K ;
Grobler, JA ;
Espeseth, A ;
Gabryelski, L ;
Schleif, W ;
Blau, C ;
Miller, MD .
SCIENCE, 2000, 287 (5453) :646-650
[6]  
KAJIKAWA A, 1975, TETRAHECRON LETT, V16, P4135
[7]   Preparation and synthetic applications of sterically hindered secondary amines [J].
Kim, HO ;
Carroll, B ;
Lee, MS .
SYNTHETIC COMMUNICATIONS, 1997, 27 (14) :2505-2515
[8]   1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: Modifications of the arylpropylpiperidine side chains [J].
Lynch, CL ;
Willoughby, CA ;
Hale, JJ ;
Holson, EJ ;
Budhu, RJ ;
Gentry, AL ;
Rosauer, KG ;
Caldwell, CG ;
Chen, P ;
Mills, SG ;
MacCoss, M ;
Berk, S ;
Chen, L ;
Chapman, KT ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA ;
Siciliano, SJ ;
Cascieri, MA ;
Carella, A ;
Carver, G ;
Holmes, K ;
Schleif, WA ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (01) :119-123
[9]   1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV [J].
Lynch, CL ;
Hale, JJ ;
Budhu, RJ ;
Gentry, AL ;
Mills, SG ;
Chapman, KT ;
MacCoss, M ;
Malkowitz, L ;
Springer, MS ;
Gould, SL ;
DeMartino, JA ;
Siciliano, SJ ;
Cascieri, MA ;
Carella, A ;
Carver, G ;
Holmes, K ;
Schleif, WA ;
Danzeisen, R ;
Hazuda, D ;
Kessler, J ;
Lineberger, J ;
Miller, M ;
Emini, EA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) :3001-3004
[10]   A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1 [J].
Siciliano, SJ ;
Kuhmann, SE ;
Weng, YM ;
Madani, N ;
Springer, MS ;
Lineberger, JE ;
Danzeisen, R ;
Miller, MD ;
Kavanaugh, MP ;
DeMartino, JA ;
Kabat, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :1905-1913